ENTITY
Wuxi Biologics

Wuxi Biologics (2269 HK)

587
Analysis
Health CareChina
WuXi Biologics (Cayman) Inc. is a leading open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology, and medical device industries, with operations in China, U.S., and Iceland. We provide a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. Our services are designed to help our global partners in shortening the cycle and lowering the cost of drug and medical device R&D through cost-effective and efficient solutions.
more
17 Jul 2022 12:47

Hong Kong Connect Flows: Tencent, Geely, Meituan, Wuxi Biologics

We highlight southbound weekly Hong Kong inflows into Tencent, Geely, as well as outflows from Meituan, and Wuxi Biologics.

Logo
450 Views
Share
17 Jul 2022 11:04

HK Short Interest: Innovent Biologics, Yeahka, CR Beer, Great Wall Motor

We highlight week on week short interest changes in Innovent Biologics, Yeahka, CR Beer, Great Wall Motor based on the latest HK SFC short...

Logo
418 Views
Share
05 Jul 2022 16:15

Hong Kong Connect Flows Monthly (June): Li Auto, Kuaishou, HKEx, Xpeng

We highlight the 7th month of consecutive inflows from mainland to HK and individual stocks with top inflows: Li Auto, Kuaishou, HKEx, Xpeng.

Logo
467 Views
Share
05 Jul 2022 10:52

HK Short Interest: Short Increased for Alibaba, Geely, Wuxi Biologics, Li Auto

We highlight week on week short interest increases in Alibaba, Geely, Wuxi Biologics, Li Auto based on the latest Hong Kong SFC short aggregate...

Logo
385 Views
Share
12 Jun 2022 10:58

Hong Kong Connect Flows: Kuaishou, Wuxi Biologics, HKEx

We highlight weekly southbound Hong Kong connect inflows into Kuaishou, Wuxi Biologics, and Hong Kong Exchange, and outflows from CNOOC, China...

Logo
422 Views
Share
x